Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

Results View source PDF Explain this filing

BIOFILCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.9%Reaction day

₹49.70

prior close

₹49.35

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-2.9% vs market

Pharmaceuticals peers, median of 147sector-0.1%-2.8% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 2.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.8

10m

-2.7

15m

-2.4

30m

-2.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.9+0.1-2.9-0.1-2.8

Next day

-2.4-0.2-2.2-0.2-2.2

-0.3+0.3-0.7-0.2-0.1

+9.5+0.9+8.6+0.0+9.5

+7.6+0.8+6.9+0.0+7.6

+6.1+2.2+3.9+0.6+5.5

+5.3+3.4+1.9+1.4+3.9

15d

-6.0-0.8-5.2-2.9-3.1

-7.4+2.9-10.4+0.3-7.7

-11.6+0.8-12.4-0.4-11.2

-12.4+0.0-12.4-3.2-9.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biofil Chemicals & Pharmaceuticals Limited has filed its financial results for the quarter and full year ended March 31, 2025 with the stock exchange. This is a routine compliance disclosure under listing requirements. The filing itself does not provide the detailed numbers in the headline text shared here — investors would need to refer to the actual results PDF/attachment for revenue, profit, margin, and balance sheet figures. Based only on the announcement text, no specific financial outcomes can be confirmed.

Likely market impact

Neutral on its own — this is a procedural filing. The actual price and sentiment impact will depend on whether the underlying numbers show growth, margin improvement, or any negative surprises relative to expectations.